A WHO expert panel has advised against the use of hydroxychloroquine for prevention of COVID-19 and has stated that the drug has no significant effect on patients who have already contracted the infection.

The agency’s Guideline Development Group (GDG) expert panel wrote in the BMJ that hydroxychloroquine should not be used in the fight against COVID-19. It further stated that it will not be beneficial to explore the drug in further research studies of possible COVID-19 treatments. As per experts, this “strong recommendation” comes after high-certainty evidence from six randomized controlled trials that included over 6,000 individuals, both with and without exposure to COVID-19… (Reuters, March 2, 2021)